Skip to main content
Clinical Trials/ACTRN12620001028998
ACTRN12620001028998
Completed
未知

Investigating the Efficacy of Chest Pressure for Direct Current Cardioversion in Atrial Fibrillation: A Randomised Control Trial (Pressure-AF)

Cardiovascular Department, John Hunter Hospital0 sites311 target enrollmentStarted: October 9, 2020Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Cardiovascular Department, John Hunter Hospital
Enrollment
311

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Has atrial fibrillation
  • Age 18 or older
  • Referred for direct current cardioversion
  • Three weeks of therapeutic anti\-coagulation prior to cardioversion or trans\-oesophageal echocardiography to exclude left atrial appendage thrombus.

Exclusion Criteria

  • Pregnancy or Breastfeeding
  • Inability to provide informed consent
  • Other atrial tachyarrhythmias (atrial flutter of multifocal atrial tachycardia)
  • Medical comorbidity where anticoagulation is contra\-indicated

Investigators

Sponsor
Cardiovascular Department, John Hunter Hospital

Similar Trials